| Statutory Instrument | |
 | |
| Citation | SI 2012/1916 |
|---|---|
| Territorial extent | United Kingdom |
| Dates | |
| Made | 19 July 2012 |
| Laid before Parliament | 24 July 2012 |
| Commencement | 14 August 2012 |
| Revoked | |
| Other legislation | |
| Amends | Medicines Act 1968 |
| Transposes | Directive 2010/84/EU |
| Amended by | Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 |
Status: Current legislation | |
| Text of statute as originally enacted | |
The Human Medicines Regulations 2012 in the United Kingdom were created, under statutory authority of the European Communities Act 1972 and the Medicines Act 1968 in 2012. The body responsible for their upkeep is the Medicines and Healthcare products Regulatory Agency. The regulations partially repealed the Medicines Act 1968 in line with EU legislation.[1][2][3][4]
- ^ "How will the new Human Medicines Regulations affect your practice?". Royal Pharmaceutical Society. 3 August 2012.
- ^ Medicines, Ethics and Practice 39: The professional guide for pharmacists. Royal Pharmaceutical Society of Great Britain. 18 July 2015. p. 25.
- ^ Appelbe, Gordon E.; Wingfield, Joy (2013). Dale and Appelbe's Pharmacy and Medicines Law (10 ed.). Pharmaceutical Press. p. 22. ISBN 9780853699897.
- ^ "Legislation covering medicines". Department of Health (N.I.). 18 August 2015. Retrieved 18 December 2020.
Please note that the Human Medicines Regulations 2012 repealed aspects of the Medicines Act 1968 as follows...